Evidence map›Paper›PMID 32503973›Full record

ArticleNature communications2020

Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.

Hao Li, Iannis E Adamopoulos, Vaishali R Moulton, Isaac E Stillman, Zach Herbert, James J Moon, Amir Sharabi, Suzanne Krishfield, Maria G Tsokos, George C Tsokos

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Machine learning and multi-omics integration identifies immunological predictors and mechanistic insights in autoimmune encephalitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Characterization and effective expansion of CD4Molecular therapy. Methods & clinical development · 2025
    Article
  15. Article
  16. CD3Frontiers in immunology · 2025
    Review
  17. Association of TCRαβFrontiers in immunology · 2025
    Article
  18. Article
  19. Article
  20. Double-negative T cells in pediatric rheumatic diseases.Clinical and experimental pediatrics · 2024
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hao LiDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Iannis E AdamopoulosDivision of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA, 95817, USA.
Vaishali R MoultonDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Isaac E StillmanDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
Zach HerbertMolecular Biology Core Facilities, Dana-Farber Cancer Institute, 21-27 Burlington Ave, Boston, MA, 02215, USA.
James J MoonCenter for Immunology and inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.ORCID http://orcid.org/0000-0001-8246-931X
Amir SharabiDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Suzanne KrishfieldDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Maria G TsokosDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
George C TsokosDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. gtsokos@bidmc.harvard.edu.ORCID http://orcid.org/0000-0001-9589-2360
Beth Israel Deaconess Medical Center · USDana-Farber Cancer Institute · USHarvard University · USUniversity of California, Davis · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
RESEARCH TRAINING IN NEPHROLOGYT32DK007199 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI POLLAK, MARTIN R. · 1986 to 2022
$6.0M
The IL-23/IL-17 Axis in Inflammatory ArthritisR01AR062173 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEVY, DAN · 2012 to 2025
$4.9M
Role of splicing factor SRSF1 in T cell function and autoimmunityR01AR068974 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ADAMOPOULOS, IANNIS ELIAS · 2016 to 2020
$2.2M
Self Antigen Specific CD4 Positive T cellsR01AI107020 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MOON, JAMES J · 2014 to 2018
$2.1M
NIAID NIH HHS R01 AI107020NIAMS NIH HHS R01 AR062173NIAMS NIH HHS R01 AR068974NIDDK NIH HHS P30 DK043351NIDDK NIH HHS T32 DK007199
6 · The paper itself

Abstract

Mature double negative (DN) T cells are a population of αβ T cells that lack CD4 and CD8 coreceptors and contribute to systemic lupus erythematosus (SLE). The splenic marginal zone macrophages (MZMs) are important for establishing immune tolerance, and loss of their number or function contributes to the progression of SLE. Here we show that loss of MZMs impairs the tolerogenic clearance of apoptotic cells and alters the serum cytokine profile, which in turn provokes the generation of DN T cells from self-reactive CD8

Indexed as

Adoptive TransferAnimalsAutoantigensDisease Models, AnimalDisease ProgressionFemaleHumansImmune ToleranceInterleukin-17Ki-67 AntigenLupus Erythematosus, SystemicMacrophagesMiceMice, KnockoutReceptors, Antigen, T-Cell, alpha-betaT-Lymphocyte SubsetsAutoantigensInterleukin-17Ki-67 AntigenReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID32503973
PMCPMC7275084
OpenAlexW3033330880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.